Trials / Recruiting
RecruitingNCT05977751
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 573 (estimated)
- Sponsor
- Femasys Inc. · Industry
- Sex
- Female
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Detailed description
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FemBloc | Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes. |
Timeline
- Start date
- 2023-10-31
- Primary completion
- 2029-12-01
- Completion
- 2031-06-01
- First posted
- 2023-08-04
- Last updated
- 2026-03-03
Locations
8 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05977751. Inclusion in this directory is not an endorsement.